Learn More
Selleck Chemical LLC Ixazomib Citrate (MLN9708) 50mg 1201902-80-8

Supplier: Selleck Chemical LLC S218150MG

Ixazomib Citrate (MLN9708) immediately hydrolyzed to Ixazomib (MLN2238), the biologically active form, on exposure to aqueous solutions or plasma. Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic (?5) site of the 20S proteasome with IC50/Ki of 3.4 nM/0.93 nM in cell-free assays, less potent to ?1 and little activity to ?2. Ixazomib (MLN2238) induces autophagy. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.